✦ LIBER ✦

Differences among the parenteral platelet glycoprotein IIb/IIIa inhibitors and implications for treatment

✍ Scribed by James E Tcheng

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Glycoprotein IIb-IIIa inhibition with ab

✍ Wojciech Mazur; Grzegorz L. Kaluza; Shelly Sapp; Craig Balog; Eric J. Topol; Dan 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 105 KB

Differences between Activation Threshold

✍ Michael B. Holmes; Burton E. Sobel; Diantha B. Howard; David J. Schneider 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 144 KB

Platelet glycoprotein IIb/IIIa inhibitor

✍ David J. Harnick; David A. Vorchheimer 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 307 KB

Additive effects between platelet concen

✍ Rosemarie Reiter; Petra Jilma-Stohlawetz; Michaela Horvath; Bernd Jilma 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 211 KB

Ornatins: potent glycoprotein IIb-IIIa a

✍ Paul MAZUR; William J. HENZEL; Jana L. SEYMOUR; Robert A. LAZARUS 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 983 KB

Ornatins: potent glycoprotein IIb-IIIa a

✍ Paul MAZUR; William J. HENZEL; Jana L. SEYMOUR; Robert A. LAZARUS 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 208 KB